Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?

Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalReview article

27 Scopus citations
Original languageEnglish (US)
Pages (from-to)153-156
Number of pages4
JournalInternational Journal of Neuropsychopharmacology
Volume8
Issue number2
DOIs
StatePublished - Jun 1 2005

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this